Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Opinion & Analysis Algernon Pharmaceuticals Inc. C.AGN

Alternate Symbol(s):  AGNPF

Algernon Pharmaceuticals is a clinical stage drug development company focused on the disease areas of stroke, idiopathic pulmonary fibrosis (IPF) & chronic cough. The company's business model is highly capital efficient and strives to deliver maximum shareholder value. Algernon's unique approach to drug discovery is based on the concept of drug repurposing.


Opinion & Analysis (CSE:AGN)

    Biopharma Co. Makes Major Headway Toward Clinical Trials for Treatment of Stroke

    Dave Jackson June 16, 2021

    Flying Under the Radar with a Possible COVID-19 Treatment

    Stockhouse Editorial September 9, 2020

    Small-Cap Pharma Fast-Tracking Repurposed Drug for Covid-19

    Streetwise Reports May 29, 2020

    Buzz on the Bullboards: Coronavirus, Esports, and Uranium Plays

    Omri Wallach April 16, 2020

    Buzz on the Bullboards: HOT Coronavirus Healthcare Stocks

    Omri Wallach March 19, 2020